D-0451-2022 Class II Terminated
FDA drug recall D-0451-2022 was initiated by American Health Packaging on Dec 20, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Mar 9, 2023). Affected quantity: 6,637 500-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 2, 2022
- Initiation Date
- Dec 20, 2021
- Termination Date
- Mar 9, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,637 500-count bottles
Product description
Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA
Code information
Lots# 21141983, 21141984 and 21141985, Exp 03/31/2023; Lots# 21142017, 21142018, 21142019, Exp 02/28/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0451-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026